73 related articles for article (PubMed ID: 19460128)
21. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
Tabone MD; Landman-Parker J; Arcil B; Coudert MC; Gerota I; Benbunan M; Leverger G; Dosquet C
Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245
[TBL] [Abstract][Full Text] [Related]
22. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms.
Bodey B; Psenko V; Lipsey AL; Kaiser HE
Anticancer Res; 1996; 16(1):219-24. PubMed ID: 8615612
[TBL] [Abstract][Full Text] [Related]
23. Fetuin-A serum concentrations in healthy children.
Wigger M; Schaible J; Muscheites J; Kundt G; Haffner D; Fischer DC
Ann Clin Biochem; 2009 Nov; 46(Pt 6):511-3. PubMed ID: 19729505
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of midkine expression in pancreatic head carcinoma.
Maeda S; Shinchi H; Kurahara H; Mataki Y; Noma H; Maemura K; Aridome K; Yokomine T; Natsugoe S; Aikou T; Takao S
Br J Cancer; 2007 Aug; 97(3):405-11. PubMed ID: 17622248
[TBL] [Abstract][Full Text] [Related]
25. [Selectins in the pathogenesis and diagnosis of early atherosclerotic changes in children and adolescents with risk factors (obesity, hypertension and diabetes)].
Głowińska B; Urban M; Peczyńska J; Florys B
Przegl Lek; 2004; 61(9):935-9. PubMed ID: 15803902
[TBL] [Abstract][Full Text] [Related]
26. Serum and CSF soluble CD26 and CD30 concentrations in healthy pediatric surgical outpatients.
Delezuch W; Marttinen P; Kokki H; Heikkinen M; Vanamo K; Pulkki K; Matinlauri I
Tissue Antigens; 2012 Oct; 80(4):368-75. PubMed ID: 22861386
[TBL] [Abstract][Full Text] [Related]
27. Serum osteoprotegerin levels in healthy controls and cancer patients.
Lipton A; Ali SM; Leitzel K; Chinchilli V; Witters L; Engle L; Holloway D; Bekker P; Dunstan CR
Clin Cancer Res; 2002 Jul; 8(7):2306-10. PubMed ID: 12114435
[TBL] [Abstract][Full Text] [Related]
28. Circulating growth factor levels are associated with tumorigenesis in neurofibromatosis type 1.
Mashour GA; Driever PH; Hartmann M; Drissel SN; Zhang T; Scharf B; Felderhoff-Müser U; Sakuma S; Friedrich RE; Martuza RL; Mautner VF; Kurtz A
Clin Cancer Res; 2004 Sep; 10(17):5677-83. PubMed ID: 15355893
[TBL] [Abstract][Full Text] [Related]
29. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
[TBL] [Abstract][Full Text] [Related]
30. Midkine, a multifunctional cytokine, in patients with severe sepsis and septic shock: a pilot study.
Krzystek-Korpacka M; Mierzchala M; Neubauer K; Durek G; Gamian A
Shock; 2011 May; 35(5):471-7. PubMed ID: 21192283
[TBL] [Abstract][Full Text] [Related]
31. Serum midkine as a predictor of cardiac events in patients with chronic heart failure.
Kitahara T; Shishido T; Suzuki S; Katoh S; Sasaki T; Ishino M; Nitobe J; Miyamoto T; Miyashita T; Watanabe T; Takeishi Y; Kubota I
J Card Fail; 2010 Apr; 16(4):308-13. PubMed ID: 20350697
[TBL] [Abstract][Full Text] [Related]
32. Midkine and syndecan‑1 levels correlate with the progression of malignant gastric cardiac adenocarcinoma.
Hu XF; Yao J; Gao SG; Yang YT; Peng XQ; Feng XS
Mol Med Rep; 2014 Sep; 10(3):1409-15. PubMed ID: 25017879
[TBL] [Abstract][Full Text] [Related]
33. Serum levels for midkine, a heparin-binding growth factor, inversely correlate with angiotensin and endothelin receptor autoantibody titers in patients with macroangiopathy.
Salaru DL; Albert C; Königsmark U; Brandt S; Halloul Z; Heller A; Heidecke H; Dragun D; Mertens PR
Int Angiol; 2014 Aug; 33(4):372-8. PubMed ID: 25056169
[TBL] [Abstract][Full Text] [Related]
34. Serum luteinizing hormone and follicle-stimulating hormone and the response to luteinizing hormone-releasing factor in children and adolescents with isolated growth hormone deficiency.
Cohen HN; Kaplan SL; Grumbach MM
J Clin Endocrinol Metab; 1983 Oct; 57(4):855-8. PubMed ID: 6411756
[TBL] [Abstract][Full Text] [Related]
35. Increased serum concentrations of pro-gastrin-releasing peptide in patients with renal dysfunction.
Kamata K; Uchida M; Takeuchi Y; Takahashi E; Sato N; Miyake Y; Okubo M; Kodama T; Yamaguchi K
Nephrol Dial Transplant; 1996 Jul; 11(7):1267-70. PubMed ID: 8672021
[TBL] [Abstract][Full Text] [Related]
36. Midkine promoter-based conditionally replicative adenovirus for malignant glioma therapy.
Kohno S; Nakagawa K; Hamada K; Harada H; Yamasaki K; Hashimoto K; Tagawa M; Nagato S; Furukawa K; Ohnishi T
Oncol Rep; 2004 Jul; 12(1):73-8. PubMed ID: 15201962
[TBL] [Abstract][Full Text] [Related]
37. Enhanced plasma levels of advanced glycation end products (AGE) and pro-inflammatory cytokines in children/adolescents with chronic renal insufficiency and after renal replacement therapy by dialysis and transplantation--are they inter-related?
Sebeková K; Podracká L; Heidland A; Schinzel R
Clin Nephrol; 2001 Dec; 56(6):S21-6. PubMed ID: 11770807
[TBL] [Abstract][Full Text] [Related]
38. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
39. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
40. The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers.
O'Brien T; Cranston D; Fuggle S; Bicknell R; Harris AL
Cancer Res; 1996 Jun; 56(11):2515-8. PubMed ID: 8653688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
